As PEGS Europe 2024 unfolds in Barcelona, we are thrilled to be part of one of the premier global summits dedicated to protein and antibody engineering. Our participation highlights the latest developments in animal-free, yeast-expressed Bovine Serum Albumin (BSA) and its role in advancing biopharmaceutical research and therapeutic innovations.
Showcasing Animal-Free BSA and Protein Expression Advancements
With an increasing industry focus on recombinant protein production, our poster on yeast-expressed BSA (poster #B069) has sparked insightful discussions among experts in bioprocessing, therapeutic antibodies, and engineered proteins. Levprot Bioscience’s expertise in precision fermentation offers a sustainable and scalable alternative to traditional serum-derived proteins, addressing key industry needs for consistency, safety, and efficiency.
Engaging with Experts in Protein Science
PEGS Europe serves as a collaborative hub where scientists and industry leaders explore the latest in:
- Optimized recombinant protein expression for drug development and industrial applications
- Therapeutic antibody engineering for next-generation biologics
- Scalable bioprocessing techniques that enhance production efficiency
It has been an intensive and stimulating experience exchanging knowledge with global pioneers in protein science and bioengineering. The discussions here reaffirm the importance of advanced expression systems in shaping the future of biopharmaceuticals and diagnostics.
What’s Next? Meet Us at MEDICA 2024!
For those who couldn’t make it to PEGS Europe, we’ll be continuing the conversation next week at MEDICA 2024 in Düsseldorf (Hall 3E54). Whether it’s recombinant proteins, precision fermentation, or animal-free solutions, we’re excited to keep pushing the boundaries of biotechnology and biomanufacturing.
If you’re at PEGS Europe, don’t miss the chance to stop by and connect! Let’s work together to drive innovation in protein science and beyond.